Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Need for revisiting the concept of reference values.

J Henny1, C Petitclerc, X Fuentes-Arderiu

  • 1Centre de Médecine Prventive, Université Henri Poincaré-Nancy I, INSERM U525, Vandoeuvre-Lès-Nancy, France. Joseph.Henny@cmp.u-nancy.fr

Clinical Chemistry and Laboratory Medicine
|October 12, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study.

European heart journal. Acute cardiovascular care·2013
Same author

Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe.

Clinical genetics·2012
Same author

Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction.

Clinical pharmacology and therapeutics·2011
Same author

Use of recombinant factor VIIa (NovoSeven(®)) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux.

Acute cardiac care·2011
Same author

[Evaluation of management of infarction in the Franche Comté province by the use of the Franche Comté Cardiology Registry, May 2005-May 2006].

Archives des maladies du coeur et des vaisseaux·2008
Same author

Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction.

Diabetic medicine : a journal of the British Diabetic Association·2006

This study addresses the limitations in current procedures for determining reference values in clinical chemistry. It highlights the need for standardized and practical methods to estimate reference limits and assess biological variability. The study proposes recommendations for defining reference limits for each method and distinguishing biases caused by population differences from those caused by analytical methods. It also emphasizes the importance of collaboration with diagnostic manufacturers and the use of standardized statistical methods. The study concludes that international collaboration is essential to develop unified guidelines for reference value determination.

Area of Science:

  • Clinical chemistry standards and guidelines
  • Medical laboratory science
  • Health policy and regulation

Background:

Current practices for setting reference values rely on procedures that are lengthy, costly, and difficult for many laboratories to implement. While the concept is widely accepted, the methods used to estimate reference limits and assess biological variability remain inconsistent. Existing procedures are complex, leading to limited adoption by professionals such as clinical chemists and diagnostic manufacturers. This gap motivated the need to refine how reference values are defined and applied. No prior work had resolved the challenges of transferring reference limits between labs or accounting for differences in populations and methods. The lack of clear guidelines for selecting reference populations and defining statistical intervals further complicates the process. Additionally, the difficulty in distinguishing between biases caused by population differences and those caused by analytical methods remains unresolved. The absence of standardized definitions and practical recommendations has hindered the effective use of reference values in clinical settings.

Keywords:
reference value guidelinesclinical chemistry standardslaboratory reference limitsbiological variability assessment

Frequently Asked Questions

Current procedures are too complex, lengthy, and expensive, making them difficult for many laboratories to implement effectively.

Defining reference limits for each method helps account for analytical differences and ensures accurate results across different laboratory techniques.

The authors suggest that clear guidelines are needed to differentiate biases caused by population differences from those caused by analytical methods.

The study proposes standardizing statistical methods such as choosing interquartile intervals and considering centiles like 2.5 and 97.5.

Related Experiment Videos

Purpose Of The Study:

The study aims to address the limitations in the current procedures for determining reference values in clinical chemistry. It focuses on improving the feasibility and consistency of these procedures to make them more accessible to laboratories. The specific problem lies in the complexity and cost of existing methods, which prevent widespread adoption. The motivation stems from the need to provide clear, practical recommendations for defining and applying reference values. The study highlights the importance of collaboration between scientific societies, international organizations, and diagnostic manufacturers. It also emphasizes the need for standardized definitions and methods to ensure accurate and reproducible results. The goal is to make the concept of reference values more concrete and actionable for laboratory scientists and clinicians. The study seeks to identify solutions for transferring reference limits across different methods and populations.

Main Methods:

The study proposes a structured approach to evaluate and improve the procedures for estimating reference values. It involves analyzing the limitations of current methods and identifying areas for simplification and standardization. The approach includes reviewing existing guidelines and identifying gaps in their implementation. The study also emphasizes the need for collaboration with diagnostic kit manufacturers to ensure compatibility and consistency. The methods include evaluating statistical techniques for defining reference intervals and considering the impact of population variability. The study outlines practical recommendations for selecting reference populations and defining exclusion criteria. It also explores the use of new communication systems to improve the presentation of laboratory data. The study emphasizes the importance of international collaboration to develop unified guidelines for reference value determination.

Main Results:

The study highlights the need for practical recommendations to improve the estimation of reference values. It identifies key challenges such as the difficulty of transferring reference limits between laboratories using different methods. The results suggest that defining reference limits for each method may be necessary to ensure accuracy. The study also emphasizes the importance of distinguishing between biases caused by population differences and those caused by analytical methods. It proposes recommendations for selecting a homogeneous reference population and defining clear inclusion and exclusion criteria. The study suggests that statistical methods should be standardized to ensure consistency in defining reference intervals. The results also highlight the need for clearer definitions and practical guidelines for using reference values in clinical settings. The study concludes that international collaboration is essential to develop unified and actionable recommendations.

Conclusions:

The authors propose that the concept of reference values requires revision to improve its practical application in clinical chemistry. They emphasize the need for standardized procedures to estimate reference limits and assess biological variability. The authors suggest that scientific societies and international organizations should provide clear recommendations for defining and using reference values. They highlight the importance of collaboration with diagnostic manufacturers to ensure compatibility and consistency. The authors propose that reference limits should be defined for each method to account for analytical differences. They also suggest that statistical methods should be standardized to ensure accurate and reproducible results. The authors emphasize the need for clearer definitions and practical guidelines to improve the understanding and use of reference values. The study concludes that international collaboration is essential to develop unified and actionable recommendations.

The authors suggest using new information techniques and communication systems to improve the presentation of biological variability in laboratory results.

The authors propose that international collaboration is essential to develop unified and actionable recommendations for reference value determination.